Furthermore, IDeg in combination with oral antidiabetic drugs provided long-term glycemic control similar to IGlar with a lower risk for nocturnal hypoglycemia in insulin-naïve patients with T2DM [17,18]. The gene discussed is INS; the disease is Hypoglycemia.